Molecular determinants of response to PD-L1 blockade across tumor types

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-021-24112-w
Affiliations:
5
Authors:
25
Institutions Authors Share
Genentech, Inc., United States of America (USA)
20.000000
20.000000
20.000000
0.80
Foundation Medicine, Inc., United States of America (USA)
3.000000
0.12
Baylor Scott & White Health, United States of America (USA)
1.000000
0.04
Queen Mary University of London (QMUL), United Kingdom (UK)
1.000000
0.04